China Academy of Chinese Medical Sciences
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- -
- Established
- 1955-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.cacms.ac.cn/
Clinical Study of Reduning Injection for the Treatment of Influenza in Children
Phase 4
- Conditions
- Influenza in Children
- Interventions
- Drug: Reduning injectionDrug: Oseltamivir phosphate granules
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2019-12-05
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 240
- Registration Number
- NCT04183725
The Dose-Effect Relationship of Wenxin Granules in the Treatment of Atrial Premature Beats
Phase 4
Recruiting
- Conditions
- Atrial Premature Complexes
- Interventions
- Drug: Normal-dose Wenxin GranulesDrug: Twice Normal-dose Wenxin GranulesDrug: PlaceboDrug: 1/2 Normal-dose Wenxin Granules
- First Posted Date
- 2019-11-15
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 150
- Registration Number
- NCT04163835
- Locations
- 🇨🇳
Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, Beijing, China
Study on the Material Basis of Syndromes of Insomnia and the Correlation Between Infrared Image
- Conditions
- Insomnia
- First Posted Date
- 2019-10-28
- Last Posted Date
- 2019-10-28
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 180
- Registration Number
- NCT04141280
A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)
Phase 4
- Conditions
- Pelvic Inflammatory Diseases
- Interventions
- Drug: Kangfu Anti-inflammatory Suppository
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2019-07-29
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 240
- Registration Number
- NCT04035785
Key Specialized Monitoring of Clinical Safety of Pudilan Xiaoyan Oral Liquid in the Real World
- Conditions
- Respiratory Infectious Diseases
- First Posted Date
- 2019-07-24
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 10000
- Registration Number
- NCT04031651
A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome)
Phase 4
- Conditions
- Pelvic Inflammatory Diseases
- Interventions
- Drug: Qianjin Capsule of Gynaecology
- First Posted Date
- 2019-07-24
- Last Posted Date
- 2019-07-31
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 184
- Registration Number
- NCT04031664
Registration of the Study of Reyanning Mixture
Phase 4
- Conditions
- Acute Tonsillitis
- Interventions
- Drug: Reyanning mixtureDrug: amoxil capsuleDrug: amoxil capsule simulatorDrug: Reyanning mixture simulator
- First Posted Date
- 2018-10-12
- Last Posted Date
- 2018-10-12
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 144
- Registration Number
- NCT03704506
Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia
Phase 4
- Conditions
- Community-acquired Pneumonia
- Interventions
- Drug: Anerning particleDrug: control group
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2018-09-18
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 216
- Registration Number
- NCT03675178
Clinical Study of Sanjin Tablets for the Treatment of Acute Simple Lower Urinary Tract Infection
Phase 4
- Conditions
- Urinary Tract Infection Lower Acute
- Interventions
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2018-11-26
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 252
- Registration Number
- NCT03658291
Auricular Concha Electro-acupuncture for the Treatment of Depression
Early Phase 1
- Conditions
- DepressionDepressive SymptomDepressive Disorder
- Interventions
- Device: Auricular vagus nerve stimulationDrug: Citalopram
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- China Academy of Chinese Medical Sciences
- Target Recruit Count
- 106
- Registration Number
- NCT03607331
- Locations
- 🇨🇳
Institute of Acupuncture and Moxibustion, Beijing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath